Why the study?
Does diabetic duration affect hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats?
Population
16-week-old male Sprague-Dawley rats
Comparison
Streptozotocin treatment to induce Type 1… vs Control group (non-diabetic rats)
Design
Preclinical
Follow-up
Up to 20 days
Authors
Loading...
In streptozotocin rats, longer diabetes may heighten platelet-driven risk; leaves open translation to human duration effects.
Does diabetic duration affect hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats?
Hyperglycemia induces early hemorheological variations, while high platelet aggregation becomes more pronounced with longer diabetic duration, potentially contributing to endothelial dysfunction.
Yeom et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: